A compound with the SMILES Nc1c(Cl)cc(-c2csc(N3CCCC3c3nc4cc(Cl)c(N5CCCCC5)cc4n3CCCO)n2)cc1Cl has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 12.127\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Nc1c(Cl)cc(-c2csc(N3CCCC3c3nc4cc(Cl)c(N5CCCCC5)cc4n3CCCO)n2)cc1Cl
Nc1c(Cl)cc(-c2csc(N3CCCC3c3nc4cc(Cl)c(N5CCCCC5)cc4n3CCCO)n2)cc1Cl
3-[2-[1-[4-(4-amino-3,5-dichlorophenyl)-1,3-thiazol-2-yl]pyrrolidin-2-yl]-5-chloro-6-piperidin-1-ylbenzimidazol-1-yl]propan-1-ol